middle.news
Chimeric Therapeutics Secures $4.5M Boost for Cancer Cell Therapy R&D
10:21am on Monday 24th of November, 2025 AEDT
•
Healthcare
Read Story
Chimeric Therapeutics Secures $4.5M Boost for Cancer Cell Therapy R&D
10:21am on Monday 24th of November, 2025 AEDT
Key Points
Received $4.5 million R&D tax incentive refund for FY2025
Supports development of CAR T and NK cell therapies
Four clinical-stage programs targeting multiple cancers
Collaboration with University of Pennsylvania on CDH17 CAR T
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CHM
OPEN ARTICLE